It doesn’t take much to enrage the perpetually outraged Left these days. A tweet from President Donald Trump, for instance, has been known to dominate the American Pravda media’s news cycle for two or three days.
And while the angry Left made mountains out of Trump molehills, the president and the Republican-controlled Congress have been making substantial progress on agenda items shared by POTUS and GOP lawmakers — in an election year, no less.
That in and of itself is darn near historic in these highly partisan times.
As The Washington Times reports, lawmakers passed three significant pieces of legislation before the Memorial Day recess that Trump has either signed or will sign — bills that have largely been ignored by the Trump-hating Washington media (because of course coverage would paint a favorable picture of POTUS and Republicans in general).
The bills include a partial rollback of the 2010 Dodd-Frank financial regulation law, which supporters — including a number of Democrats — say will lead to more lending by small banks in smaller communities.
As Trump signed the bill, which is yet another regulation-cutting effort by a president who promised to do just that, he noted that the Republican Congress was not sitting on its laurels like the Legislative Branch so often does during election years.
“For a Congress that they say, you know, won’t be doing much because we have an election coming up, I think we’re doing an awful lot,” Trump said. “I think we’re doing more than any Congress in a long time.” (Related: Trump moving on immigration pledges as he keeps campaign promise to simply enforce the law.)
That’s not hyperbole; a number of Congress-watchers agree.
Moving on the Trump agenda
One of them is Andrew Busch, a political scientist at Claremont McKenna College in California. He told the Times that there’s been “a flurry of legislative activity recently” in addition to the overhaul of Dodd-Frank, to including important reforms to Veterans Affairs and a “right to try” law giving terminally ill patients access to experimental medications and drugs that haven’t been approved by the Food and Drug Administration.
“As a general rule, it is often more difficult to pass bills in election years, midterm or presidential, because both sides are afraid of letting the other side gain good publicity,” Busch told the Times. “However, it really depends on the balance of power in Congress, how each party perceives its electoral interests and the nature of the issue.”
The numbers also speak for themselves. Trump has signed 57 pieces of legislation so far; at the same point in the 2014 midterm year of his presidency, Obama had only signed 34. In April 2014, Obama complained about “the least productive Congress in modern history,” while, of course, doing nothing to compromise with the people’s representatives in order to get more legislation approved.
It could be that Republicans are busy in the months leading up to the midterms because, historically, the party in power loses seats in such elections. And while the Democrats have been attempting to sell the notion that a “blue wave” is coming in November, there’s no indication that’s true.
Just the opposite, in fact.
The president’s numbers continue to rise and remain high; he’s been in the high 40s for much of the spring and has touched or surpassed 50 percent at times.
Meanwhile, the generic balloting for Republicans and Democrats has been trending away from Dems and toward the GOP.
All of which makes perfect sense: Republicans are finally helping Trump accomplish his agenda, which is the very same one most GOPers have run on as well. That, and all the Democrats are selling is hate and socialism.
While the Party of Obama continues to tilt at windmills and scream bloody murder at every syllable Trump utters, he and Republicans remain hard at work making America great again.
Read more about Trump and the GOP congress at Conservatives.news.
J.D. Heyes is a senior writer for NaturalNews.com and NewsTarget.com, as well as editor of The National Sentinel.
Sources include:
Please contact us for more information.